002390Xinbang Phar.SZSE

Guizhou Xinbang Pharmaceutical Co., Ltd.

信邦制药

002390

Shenzhen Stock Exchange

BoardMain Board of Shenzhen Stock Exchange
IndustryWholesale
ISINCNE100000NG5
ListedApril 16, 2010
Websitewww.xinbang.com
IR Emailxinbang@xinbang.com
Phone(+86)851-88660261
Sourcecninfo.com.cn
Address6F, No.1, Kekai Yard, No.83, north section of Xintian Avenue, Wudang District, Guiyang, Guizhou

Company Overview

Guizhou Xinbang Pharmaceutical Co., Ltd. is a comprehensive healthcare group based in Luodian County, Guizhou Province, founded in February 2000 and listed on the Shenzhen Stock Exchange in April 2010. The company operates across the entire healthcare industry chain, which includes Healthcare Services, Medical Distribution, and Pharmaceutical Manufacturing. It aims to enhance resource sharing and operational efficiency through a platform-based model that emphasizes risk resilience and management efficiency. The company's Healthcare Services sector includes six medical institutions, such as The Affiliated Cancer Hospital of Guizhou Medical University, which is the only class A tertiary cancer hospital in the province. In the Medical Distribution sector, Guizhou Xinbang has established a comprehensive distribution network covering major hospitals in Guizhou, supported by a modern logistics center. The Pharmaceutical Manufacturing sector focuses on Chinese patent drugs and herbal products, boasting a range of essential medicines and a stable marketing network. The company emphasizes quality and safety in its products, leveraging its expertise in traditional Chinese medicine.

AI-generated from company disclosures and CNInfo data.

Company Profile

Healthcare Services. The company has 6 hospitals in the company's network, including but not limited to The Affiliated Cancer Hospital of Guizhou Medical University which is the only class A tertiary cancer hospital in Guizhou Province, The Affiliated Baiyun Hospital of Guizhou Medical University is tertiary comprehensive hospitals with high reputation. Each hospital has characteristic discipline and together they form a network of high-quality hospital with competitive advantages. Relying on the technical support and personnel training advantages of professional colleges, the company can cooperate with universities in clinical teaching, established the Baiyun Clinical Teaching Center of Guizhou Medical University, and practice the concept of operating hospitals with the development of clinical care, medical education and research. The company also has a stable team of experts and management team, and has explored a set of mature and effective medical operation mode, which has the ability to realize scientific, standardized and refined management mode. With the advantages of "Healthcare Services +" platforms, developing new treatments and technologies such as the Molecular Pathology Center and other synergistic businesses such as healthcare to increase service content and enhance service capacity, let the quality medical resources can benefit more people through new technologies. Medical Distribution. The company has the geographical advantages of regional group enterprises, established a distribution network covering major hospitals in Guizhou, and formed a full-category distribution system including drugs and equipment, thus gain advantages in the distribution network, pharmaceutical varieties, upstream and downstream customer resources and service capabilities. Based on the warehousing scale, distribution capacity, and leading modern pharmaceutical logistics and distribution system in Guizhou, the company also carries out third-party logistics services on the basis of meeting the development of our own pharmaceutical distribution business. The Ke Kai Pharmacy Ltd. has the qualification of DTP pharmacy and has formed a pharmaceutical retail network covering the company's established hospitals and major partner hospitals. The company's customer coverage rate of hospitals above the provincial level reaches more than 95 per cent, the coverage rate of primary hospitals in Guizhou reaches more than 45 per cent. Pharmaceutical Manufacturing. The company's proprietary Chinese medicine sector has a mature marketing network and stable marketing teams to maximize the role of various market resources The company’s Chinese herbal pieces' quality is reliable, with high quality customers and stable sales growth. It has taken the lead in the country in realizing the seamless link from the construction of planting base, the production of Chinese herbal pieces to their use in healthcare institutions, which effectively guarantees the product quality of the products, the safety of the clinical use of medicines, and the therapeutic effect of Chinese herbal pieces. The broader health products are classic prescriptions chosen from Masters of Traditional Chinese Medicine and nationally renowned TCM. Using high-quality, authentic Chinese herbal ingredients sourced, the company have developed a range of natural, safe and reliable food-grade herbal products that satisfy both taste preferences and health needs.

31 announcements tracked· Last: June 22, 2026

Key Financials

As of 2026-06-20T00:00:00.000+00:00
Revenue¥1.26bn
Net Profit¥48.7M
ROE0.71%
Debt Ratio17.06%
Monetary Funds¥1.15bn
Receivables¥2.35bn
Goodwill¥593.6M
Total Shares1.94bn

Announcements

31 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.